Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

48023051583_a1d0580cea_b

How do the Presidential frontrunners plan to combat the opioid crisis?

February 12, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020 Election, Bernie, Bernie Sanders, Donald Trump, Joe, Joe Biden, Trump

The widespread addiction to extremely potent, legal painkillers has decimated the lives of millions across the United States. Overdoses from …
Feature
cancer-vs-alzheimer-1080x810

ICR identifies key “microRNA” gene driving chemotherapy resistance in cancer

February 12, 2020 Research and Development Cancer, ICR, pharma

Researchers at the Institute of Cancer Research have discovered that a small RNA molecule known as microRNA gene MIR1249 contributes …
News
mjg5mzc4oa

Type 2 diabetes drug Rosiglitazone increases risk of heart problems

February 12, 2020 Research and Development British Medical Journal, diabetes, heart failure, insulin, type 2, type 2 diabetes

A new study has given further evidence that rosiglitazone can contribute to risk of heart problems and heart failure. The …
News
homeless-charity-poor-indifference

New report finds that health inequality in the UK greater than previously thought

February 12, 2020 Research and Development NHS, NICE, type 2 diabetes

Men are living seven years in poor health while women are living nearly ten years, according to a new report. …
News
191209-f-kq373-1096

Seattle Genetics and Astellas unveil positive results for Padcev-Keytruda treatment for bladder cancer

February 12, 2020 Research and Development Astellas, Cancer, Seattle Genentics, bladder, bladder cancer, keytruda, monotherapy

Seattle Genetics and Astellas reported positive results from their trials of Padcev plus Keytruda in treating bladder cancer. The data …
News
drug_testing_2019

Chinese company starts mass producing Gilead coronavirus drug

February 12, 2020 Research and Development Ebola, Wuhan, Wuhan Coronavirus, china coronavirus

A drugmaker in China said it has started mass producing Gilead Sciences Ebola drug that has the potential to fight …
News
andrea_pfeifer_edit

Working Life Interview: Dr Andrea Pfeifer, Co-Founder and CEO, AC Immune

February 11, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AC Immune, Interview, Working Life, feature, pharma

What originally set you off on your career path? Was the plan always to go into the pharma and biotech …
Feature
1740294_bertil-lindmark-webbnyhet

Galecto hires new Chief Medical Officer

February 7, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Galecto

Galecto has announced Bertil Lindmark as their new Chief Medical Officer. He began his posting on 1 February 2020.Lindmark joins …
Appointment
rob_van_maanen

New Chief Medical Officer joins Khondrion

February 7, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Khondrion has revealed that Dr Rob van Maanen has joined the company as its new Chief Medical Officer (CMO). Dr …
Appointment
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

February 7, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MERS, Sars, china coronavirus, coronavirus, coronavirus China, wuhan coronaviurs

The Wuhan coronavirus continues to dominate the news, with China admitting its handling of the crisis had shortcomings while Gilead …
News
shutterstock_349943306

85% of patients see benefit in clinical trials, but 43% were never given the option to participate, report finds

February 7, 2020 Medical Communications, Research and Development clinical trials, pharma

Patients regularly find value in participating in clinical trials, but many are not given the option by medical professionals and …
News
abbvie_0

AbbVie’s Rinvoq hits target in psoriatic arthritis sub-population at Phase 3

February 6, 2020 Research and Development AbbVie, Rinvoq, pharma, psoriatic arthritis

AbbVie has unveiled new Phase 3 data on its selective and reversible JAK inhibitor Rinvoq (upadacitinib) in the treatment of …
News

How AI is making clinical trials more accurate and affordable

February 5, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AI Clinical Trials, Apple, Apple Watch., apple watch, clinical trials

Clinical trials are one of the longest and most expensive steps of bringing a drug to market. Conor Kavanagh investigates …
Feature

NICE plans to use broader range of data in guidance

February 5, 2020 Research and Development NHS, NHS NICE, NICE

The British National Institute for Care Excellence has said it plans to use a broader range of data and analytics …
News

Bayer’s Eylea shows strong vision benefits across two regimens in post-marketing study

February 5, 2020 Research and Development Bayer, Eylea, pharma

Bayer has pulled back the curtain on new Phase 4 data for Eylea (aflibercept), revealing strong findings in the treatment …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025